Fig. 4: Drug combination enhanced the antiviral activity against SARS-CoV-2 and SARS-CoV.
From: Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2

a Chloroquine (Chl) could significantly enhance the activity of arbidol against SARS-CoV-2 while arbidol alone (0.2āμgāmlā1, Ar-0.2) did not show antiviral activity (nā=ā4). SARS-CoV-2 was treated by the indicated Ar-0.2, Chl-3.1 (3.1āμgāmlā1), or Ar+Chl. P value was compared with Chl-3.1. b Chloroquine (Chl) could significantly enhance the activity of arbidol against SARS-CoV while arbidol alone (0.4āμgĀ mlā1, Ar-0.4) did not show antiviral activity (nā=ā4). SARS-CoV was treated by the indicated Ar-0.4, Chl-6.3 (6.3āμgāmlā1), or Ar+Chl. Viral RNA copies were measured at 24āh post infection in cell supernatants. The relative RNA copy was compared to mock treated virus. P value was compared with Chl-6.3. c The antiviral activity of indicated drugs or drug combinations against SARS-CoV in mice. Mice were intranasally inoculated with SARS-CoV (5āĆā103 PFU). 8P9R (intranasal 0.5āmgākgā1, nā=ā8), arbidol (Ar, oral 30āmgākgā1, nā=ā8), chloroquine (Chl, oral 40āmgākgā1, nā=ā6), camostat (Cam, intranasal 0.3āmgākgā1, nā=ā5), Ar+Chl (nā=ā6), Ar+Cam (nā=ā6), Chl+Cam (nā=ā6), Ar+Chl+Cam (nā=ā5) and mock (nā=ā12) were given to mice at 8āh post infection. Two more doses were given to mice in the following day. Viral loads in lung tissues were measured by plaque assay at day 2 post infection. dāe The antiviral activity of 8P9R (12.5āμgāmlā1), arbidol (12.5āμgāmlā1), and chloroquine (12.5āμgāmlā1) in Vero-E6 (d, nā=ā4) and Calu-3 (e, nā=ā3) cells. Viral RNA copies in cell supernatants were measured by RT-qPCR at 24āh post infection. Relative RNA copy was normalized to mock. f The antiviral activity of indicated drugs or drug combinations against SARS-CoV-2 in hamsters. Hamsters were intranasally inoculated with SARS-CoV-2 (5āĆā103 PFU). Mock (nā=ā9), 8P9R (intranasal 0.5āmgākgā1, nā=ā4), Ar+Chl+Cam (nā=ā6), Chl+Cam (nā=ā6), Ar+Cam (3), Cam (intranasal 0.3āmgākgā1, nā=ā5), Ar (oral 30āmgākgā1, nā=ā3), and Chl (oral 40āmgākgā1, nā=ā4) were given to hamsters at 8āh post infection. Two more doses were given to hamsters in the following day. Viral loads in lung tissues were measured by plaque assay at day 2 post infection. Data are presented as meanā±āSD of independent biological samples. P values are calculated by two-tailed student t test when compared with mock. Source data are provided as a Source Data file.